The FDA extended the Prescription Drug User Fee Act date for the biologics license application seeking approval of zenocutuzumab for NRG1-positive lung and pancreatic cancer.
Ron DeSantis speaks at a news conference at a pharmaceutical warehouse run by LifeScience Logistics on May ... Florida Gov. Ron DeSantis hailed the FDA’s approval of his plan in January, calling it a ...
Following the initial detection, the agency sought to identify the specific raw ingredient in the product contaminated with Sudan dye, a red synthetic dye that is banned in Taiwan for use in ...
SMi Group Reports: Following the FDA’s release of a ... [centerforbiosimilars.com] Also in recent news were statements made by the chair of this year’s two-day conference; Richard DiCicco ...